© Copyright Nostre Net
The hydroxychloroquine drug is used in the
treatment of malaria. Apart from malaria, it is also used for the treatment of
rheumatoid arthritis, lupus erythematosus, and recently discovered
COVID-19 disease. Hydroxychloroquine is more preferable than chloroquine as it
has fewer side effects.
The growth of the global hydroxychloroquine
drug market can be contributed to the growing need for rescue medication, high
demand for hydroxychloroquine drugs, due to the outbreak of COVID-19 globally,
and increasing prevalence of chronic diseases.
The Hydroxychloroquine
Market trends is anticipated to grow at a CAGR of 26.90% significantly. The
market value is further expected to increase up to USD 714.11 Million in the
studied forecast period 2022-2030. Ipca is the global manufacturer of
hydroxychloroquine drugs. Sanofi S.A., Hikma pharmaceuticals, and Concordia
Healthcare are some of the competitors that dominate the global
hydroxychloroquine market. The key players are involved in awareness campaigns,
product approvals, mergers, and strategic collaborations to strengthen their
market positions. For instance, according to outsourcing-pharma.com, on 19 May
2020, sterling pharma kicks off hydroxychloroquine production. The US FDA
recently lifted import alerts on its plants, paving the way for the firm to
export it to the US. Cadila was already exporting it to the US, though the
numbers were not huge.
Key Players
Some of the key players in
hydroxychloroquine market are Zydus Cadila (India), Ipca laboratories
(India), Sanofi S.A. (France), Hikma Pharmaceuticals (UK), Novartis
International AG (Switzerland), Teva Pharmaceutical, Industries Ltd (Israel), Apotex
Corporation (Canada), Mylan N.V. (US), Concordia Healthcare (UK), Amneal
Pharmaceuticals, Inc. (US), Taj Pharmaceuticals (India), Sun Pharmaceutical
Industries Ltd. (India), Shanghai Pharmaceuticals Holding (China), Hanlim
Pharmaceutical (South Korea), Kyung Poong (South Korea), Laurus Labs Limited
(India), Covis Pharmaceuticals, Inc. (Switzerland), Lupin Pharmaceutical
(India).
Segmentation
The hydroxychloroquine market has been
segmented by strength and application
Based on the strength, the hydroxychloroquine
market has been segmented into 200mg, 400mg, and others. Among them, 200mg is
commonly used to cure arthritis as well as for malaria and recently for
COVID-19. 400 mg dosage is commonly used for the treatment of Malaria, Lupus
Erythematosus, and Rheumatoid Arthritis once a week for the adults. In
addition, the increasing usage of hydroxychloroquine for COVID-19 treatment is
driving the growth of the market.
Based on the application, the segment
is classified into Coronavirus disease (COVID 19), Malaria, Rheumatoid
Arthritis, Lupus Erythematosus, Porphyria cutanea tarda (PCT), Q fever, and
others. The malaria segment dominated the global hydroxychloroquine market and
held the largest market share in 2019. The hydroxychloroquine is used for the treatment
of malaria, which is caused by the mosquito bite. It is a reasonably
inexpensive drug and generally sold as over the counter drug in the countries
such as India.
Regional Analysis
The market has divided into regions like
the Americas, Europe, Asia-Pacific, the Middle East, & Africa. America is
further segmented into North America and Latin America. America does not
produce anti-malarial drugs, as there is no prevalence of malaria. The outbreak
of COVID-19 has increased demand. North America is predicted to be one of the
largest markets for hydroxychloroquine in the coming years. The European hydroxychloroquine
market report has been categorized as western Europe and eastern Europe.
Western Europe further classified as Germany, France, the UK, Italy, Spain, and
the rest of western Europe. Asia-Pacific is classified as China, India, Japan,
Australia, South Korea, and the rest of Asia-Pacific. India is the largest
manufacturer of antimalarial drugs. The hydroxychloroquine market in the Middle
East & Africa is categorized into the Middle East and Africa.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
A protective mask acts as a device that
covers the mouth, nose, or both of a patient who requires positive pressure,
non-invasive ventilation, or continuous positive pressure ventilation. Healthcare
Protective Masks Market size was estimated to be USD 2,050.2 Million in 2019
and Healthcare Protective Masks Market is expected to reach USD 9.88 Billion by
2030. It is predicted to grow at a CAGR of 5.7% from 2022 to 2030. Furthermore,
the rising prevalence of age-related diseases, mass manufacturing operations in
Southeast Asian countries, increasing investments in healthcare facilities, and
increasing levels of pollution, are also expected to boost the market during
the forecast period.
However, manufacturers providing
low-quality face masks, and a rise in prices of face masks are expected to
restrain the growth of the healthcare protective masks market.
Several market players such as 3M, Cardinal
Health Inc., and Medline Industries Inc. among others currently dominating the
global healthcare
protective masks market.
Regional Analysis
The market has been divided, by region,
into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The
Americas region held the largest market, owing to the rise in COVID-19 cases in
the region. The healthcare protective masks market in the Americas has further
been branched into North America and Latin America, with the North American
market divided into the US and Canada. The European healthcare protective masks
market has been categorized as Western Europe and Eastern Europe. The Western
European market has further been classified as Germany, France, the UK, Italy,
Spain, and the rest of Western Europe. The healthcare protective masks market
in Asia-Pacific has been segmented into China, India, Japan, Australia, South
Korea, and the rest of Asia-Pacific. Due to the increasing number of surgical
procedures, the market in Asia-Pacific is expected to be the fastest-growing.
The healthcare protective masks market in the Middle East & Africa has been
divided into the Middle East and Africa.
Key Players
Some of in the global healthcare
protective masks market players are 3M (US), Cardinal Health, Inc. (US),
Narang Medical Limited (India), Mölnlycke Health Care AB (Sweden), Henry
Schein, Inc. (US), Medline Industries, Inc. (US), Sterimed (India), Honeywell
International Inc. (US), Kimberly-Clark Corporation (US), Ansell Ltd
(Australia), Dynarex Corp. (US)
Segmentation
Global Healthcare Protective Masks Market
has been segmented based on the Product Type and The End User.
Based on the product type, the global
healthcare protective masks have been segmented into surgical masks, anesthesia
masks, and respirators. The surgical masks segment is expected to be the
largest market segment.
On the basis of end user, the market is
segmented into hospitals & clinics, and ambulatory surgical centers. The
ambulatory surgical center segment is expected to be the fastest-growing
segment.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
The neurology
devices market share was valued at USD 13.5 billion in 2022 and is
projected to grow from USD 14.55 Billion in 2023 to USD 22.84 billion by 2030,
exhibiting a compound annual growth rate (CAGR) of 7.80% during the forecast
period (2023 - 2030). Neurology is a discipline of medicine that focuses on
problems with the nervous system, including the brain, blood vessels, muscles,
and nerves. The treatment of neurological disorders like Alzheimer's, tumors,
and Parkinson's disease with neurovascular devices like interventional devices,
cerebrospinal fluid management devices, and others. Shunts, valves, and
external drainage systems are also used in cerebrospinal fluid management
devices to facilitate the flow of cerebrospinal fluid and remove excess fluid
from the brain.
A shunt also provides an alternative fluid
conduit by which the cerebrospinal fluid avoids obstacles in the brain's fluid
compartments as well as acts whenever fluid absorption is otherwise impeded.
The stent-created bypass relieves the extra fluid buildup which causes
hydrocephalus. Furthermore, numerous other devices or instruments, like
catheters, ultrasonic aspirators, stents, and stereotactic systems, are
available on the market for the therapy of neurological devices market.
Key Players
Some of
the key players in the global neurology devices market are B. Braun
Melsungen AG, Boston Scientific Corporation, Integra LifeSciences Holdings
Corporation, Johnson and Johnson, Medtronic Inc., St. Jude Medical, Inc.,
Stryker Corporation, W.L. Gore & Associates, Inc., and Esaote, among others
Regional
Classification
In 2018, the neurology devices market was
dominated by North America, followed by Europe. Increased government funding
for the R&D of novel neurological devices and a rise in prevalence of
neurological disorders like Alzheimer's and Parkinson's disease are driving the
overall expansion of the North American neurology devices market. Furthermore,
the widespread availability of innovative neurological equipment and a
well-developed healthcare infrastructure and the existence of major companies
all contribute to the market's development.
However, due to a growth in the frequency
of neurological illnesses and the availability of a big patient pool in this
region, LAMEA is expected to develop at the fastest pace over the analysis
period. Furthermore, major factors driving the area's neurology devices market
development include rising per capita income in many nations, increased
government initiatives to boost the healthcare sector, as well as a sharp rise
in leading manufacturers' focus on expanding their geographic presence in
emerging countries to capture the largest share of the neurology devices
market.
Market
Segmentation
The cerebrospinal fluid management devices
segment dominated the neurology
devices market outlook by product in 2018, and this trend is expected to
continue over the projected period. It is due to an increase in the use of
these devices for neurological device diagnosis. These management devices, for
example, are frequently employed in the diagnosis and treatment of multiple
sclerosis, encephalitis, myelitis, and other neurological diseases.
The hospital segment captured the most
market share by end-user in 2018, and this trend is expected to continue during
the projected period. This is due to the simple accessibility of neurological
devices in hospital settings and patients' preference for visiting hospitals
for neurological device diagnosis and therapy.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Getting a
different medical opinion is when a patient seeks a medical opinion on their
diagnosis and treatment plan from another, or a few other expert doctors, in
order to confirm the diagnosis and authenticate their treatment. As per MRFR,
the Medical
Second Opinion Market Size,is predicted to gain an income of USD 9751.58 Million at a CAGR of 15.8 % by
2027.
Strong
growth for expert advice due to the COVID 19 outbreak, the financial, health,
and legal costs related to treatment, and the heightened need for better
diagnosis and treatment planning, are projected to propel the medical second
opinion market forward.The COVID 19 outbreak and the increased demand for better diagnosis and
treatment planning are prepared to push the medical second opinion market
forward.
The
renowned payers in the medical second opinion market areCleveland Clinic MyConsult,
Partners Healthcare, HCA Hospitals (US), Teladoc Health, Inc., (US),
SecondOpinionExpert, Inc., (California), DoctorSpring (California), 2nd MD
(Houston), Amradnet (US), Johns Hopkins Medicine, and XMRI.COM.
Competitive
Analysis
The need to establish a quick and
profitable management strategy is predicted to impact the market in the near
future. The market's conflict between demand and supply is investigated to
generate a measured development framework. In the coming future, competitors'
potential to stimulate market transformation will proceed to grow at a steady
rate. Since the market requires an additional drive to achieve consistency in
such a situation, cooperation from administrative authorities and governments
is increasing. The focus on transformation is forecast to expand in the
following years, as user expectations must be addressed more effectively to
recover the global medical second opinion services market. In the subsequent
years, the requirement to ameliorate losses incurred by the current public
health crisis is projected to be the exclusive focus of market applications. In
particular, there will be a need to provide a helping hand to enterprises in
the approaching phase.
Segmental
Analysis
The
segmental overview of the medical second opinion market Insightshas been conducted based on services,
providers, applications, and sources of services. The global medical second
opinion market has been divided into three categories based on services:
post-acute care nursing, medical condition management, and medical peer review
services. The market has been divided into cancer, neurological disorders,
respiratory disorders, a diabetes, cardiac disorders, nd ocular disorders based
on application. The market has been divided into two categories based on the
source of service: in-house and outsourced. The market has been divided into
online physicians' portals, medical second opinion companies, hospital
physicians/specialties, and health insurance companies based on providers.
Detailed
Regional Analysis
Americas
is the largest regional market. The increasing need to improve diagnosis in the
region is expected to drive the market. Moreover, increasing treatment planning
amongst people is also expected to contribute the market growth. The medical
second opinion market in Europe held the second-largest position owing to
increasing medical errors. Asia-Pacific is the fastest-growing segment due to
the developing economy across the region. The medical second opinion is high in
the case of chronic diseases such as diabetes and cancer. The Middle East and
Africa's improving treatment plans and diagnosis with ease of interaction among
patients is expected to boost the second opinion's medical second opinion
market growth.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Nebulizers
Market share is expected to hold a value of USD 1.27 Billion by 2030 and is
expected to register a growth of 6.90% from 2022 to 2030. Drug wastage is
one of the biggest challenges faced by the healthcare sector following device
usage. Sensing the opportunity, several companies are coming up with highly
innovative nebulizers such as vibrating mesh, breath-enhanced and
breath-actuated nebulizers that cut down drug wastage and enhance the
efficiency of drug delivery. Such nebulizers help elevate the output rate while
reducing the entire administration period. Besides, the heightened demand for
healthcare devices that can be used at home and the surging consumption of
cigarettes, alcohol and tobacco that cause respiratory disorders should also
enhance the market size in the years to come.
Most of the renowned vendors are focused on
promotion campaigns, mergers, collaborations, as well as product approvals, to
uplift their market positions. A case in point, in March 2021, PARI Pharma
GmbH, a reputed developer of aerosol delivery systems that are based on the
eFlow Technology, confirmed LAMIRA Nebulizer System’s authorization for
delivering Insmed's ARIKAYCE in the Japanese market.
Companies
Profiled
Braun Melsungen AG (Germany), Invacare
Corporation (US), Drive DeVilbiss Healthcare (US), Briggs Healthcare (US), GF
Health Products, Inc. (US), PARI (US), Agilent Technologies Inc. (US),
Koninklijke Philips N.V. (Netherlands), OMRON Healthcare (Japan), Vectura Group
PLC (UK), Beurer GmBH (Germany), Rossmax International Ltd (Taiwan), are the
prominent firms in the global market.
Segmental
Status
The nebulizers
market outlook has been dissected with respect to type, usage, portability
along with end user.
The nebulizer types that are available in
the global market are jet, ultrasonic as well as mesh. The types of mesh
nebulizers include passive and active. From the main types of nebulizers, the jet
nebulizers types should procure the top position over the following years since
they are far more cost-effective compared to other types in the market and
should therefore, note higher demand.
Usage-wise, the major segments can be reusable
and disposable. Out of these, the leading spot has been secured by disposable
nebulizers, as these witness significant demand given the provision of reduced
infection rate as well as wastage.
Portable and tabletop are identified as the
main segments, as per portability. The portable nebulizers market has been
progressing at the fastest pace, thanks to its convenient coupled with ease of
use.
Home care, along with hospitals &
clinics are the industry end-users covered in the MRFR study. In light of the
expanding patient base, hospitals and clinics have emerged as the leading
segment in the market. But, it is likely that the homecare segment will achieve
the fastest growth rate in the years ahead.
Regional
Status
Europe/EU, the Americas, Asia Pacific/APAC
and Middle East and Africa/MEA are the key regions across which the nebulizers
market is expected to note growth over the review period.
The American market has emerged the clear
winner out of the regions, on account of the alarming growth in respiratory
disorders and the favorable reimbursement schemes available in the region. The
region’s performance will be further bolstered by the fact that consumers here
follow a fast-moving lifestyle and therefore, opt for portable devices that are
compact and have multiple advanced features. This scenario is also favored by
the escalating cases of asthma and a number of airway diseases in the region.
The European market stands second and is
expected to attain higher growth in the coming years, in view of the fast-expanding
elderly patient base affected by several respiratory diseases. Frequent
technological advances and the emergence of new and more sophisticated
nebulizers in the market should be favorable as well.
The market size in Asia Pacific is expected
to grow at the fastest pace during the analysis period, largely due to the
rapidly surging cases of respiratory diseases, especially among the massive
geriatric populace. The soaring trend of preventive care, along with surge in
government initiatives to spread awareness among people while also encouraging
technological innovations will benefit the APAC industry over the years to
follow.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Electronic Trial Master File (eTMF)
Systems Market overviewBy Component, Deployment Mode, End User, Region Forecast to 2030. Electronic Trial Master File (eTMF) Systems Market Size was valued
at USD 0.78 billion in 2022.
The Electronic Trial Master File (eTMF)
Systems market industry is projected to grow from USD 0.89 Billion in 2023 to
USD 1.96 billion by 2030, exhibiting a compound annual growth rate (CAGR) of
14.11% during the forecast period (2023 - 2030).
Electronic Trial Master File Systems have
grown in favor across a variety of enterprises, including pharmaceutical and
biotechnology firms, in the digital age. The eTMF Systems market is growing in
popularity since the novel solution allows customers to get a real-time view of
clinical papers and manage them effectively. The global eTMF systems market is
growing due to a number of factors, including increased acquisitions, new
solution and service deployments, and partnerships by leading market
participants, as well as an increase in the number of clinical trial studies.
Competitive Dynamics
The notable players of the market are Aurea,
Inc. (US), Covance Inc. (US), ePharmaSolutions (US), MasterControl, Inc. (US),
Oracle (US), Phlexglobal (UK), SureClinical Inc. (US), TransPerfect (US), Veeva
Systems (US), and Wingspan (IQVIA) (US).
Segmental Analysis
The eTMF Systems Market can be divided into
two categories based on their components: software and services. Both market
categories have been performing well, and they are expected to contribute to
the Electronic Trial Master File (eTMF) Systems Market's growth over the
anticipated time.
The eTMF Systems Market can be divided into
on-premise and web/cloud-based systems based on the deployment model. According
to the eTMF Systems Market Forecast, the web/cloud segment will likely be the
fastest-growing segment in the near future.
According on the end-user, the eTMF Systems
Market can be segmented into contract research organizations, biotechnology and
pharmaceutical businesses, and others. Due to the increased demand for exact
master file solutions, contract research companies are likely to acquire a
significant chunk of the Electronic Trial Master File (eTMF) Systems Market
Share throughout the forecasted period.
Regional Overview
The global eTMF
Systems Market research Report is segmented into four regions: the
Americas, Europe, Asia Pacific, and the Middle East and Africa. The Americas is
the most important regional sector in terms of market growth on a worldwide
scale. Oracle and Veeva Systems are two key players that control a considerable
percentage of the Electronic Trial Master File (eTMF) Systems Market Value.
On a worldwide scale, the European market
has been performing admirably. The high level of support from regulatory bodies
is one of the market's primary drivers. The adoption of quickly growing
technology in the market is one of the primary Electronic Trial Master File
(eTMF) Systems market trends that is consistent across various regional
sectors.
The Asia Pacific region is expected to
perform well in the market over the anticipated period. Due to the rising
adoption rate of eTMF software and services in Asian countries, the eTMF
systems market in this region is expected to develop at the quickest rate
throughout the assessment period.
The Middle East and Africa regional
division is the smallest in terms of geographical area. The inadequate
development of the region's healthcare infrastructure, as well as a lack of
exposure to digital technologies and innovations, are the key factors for the
eTMF Systems Market's limited growth. Each geographical division is projected
to contribute to global market performance during the forecasted time.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
The medical
imaging market share was valued USD 39.19 in 2021 and is expected to reach
USD 64.99 billion by 2030 at 7.10% CAGR during the forecast period 2022-2030;
this and other vital market figures have been revealed in Market Research
Future's detailed report on the subject. Advancements in technology have
introduced medical imaging systems that can show diffuse and focal pathologies
in a variety of organs.
Increasing prevalence of various chronic diseases, cardiac
diseases, and neurological diseases have resulted in increased demand for
medical imaging services. Healthcare as a sector is growing exponentially
across the world, with increasing investments being made in state of the art
systems. Emerging economies are expected to make huge development in catching
up to developed economies with regards to providing patients with advanced
systems which are widely available. Several market leaders are involved in
comprehensive research and development activities to offer further advancements
in the highly competitive market. Additionally, there is a high preference and
demand for minimally invasive treatments and diagnostic procedures. This combined
with rising numbers of diagnostic imaging centers are likely to lead to surging
growth for the global medical imagining market.
Presently, health care reforms have not caught up to
healthcare trends, particularly in emerging and underdeveloped economies which
will pose a challenge to the growth of the market. Moreover, medical imaging
devices are expensive. However, emerging economies represent high promise and
opportunities for growth in the coming years, and R&D activities will
likely expand market value.
Regional Analysis
The Americas, with their inclusion of North America, account
for the most significant share of the global medical imaging market. The
presence of a developed healthcare sector, swift adoption of technological
advancements and the regions role in advancing the market are significant
factors responsible for it's leading market position. Europe is the second most
significant region due to high government support for advanced healthcare being
made available to the regions patient population.
Meanwhile, the APAC market has a rapidly developing
healthcare sector with the government's full support. The region is advancing
rapidly in its adoption and demand for advanced healthcare and is expected to
be a significant market in the future.
Market Segmentation
The Global Medical
Imaging Market outlook is segmented based on product type, application,
end-user, and region. By product type, the market is segmented into magnetic
resonance imaging (MRI), X-Ray imaging systems, ultrasound imaging systems,
nuclear imaging systems, and computed tomography (CT) scanners. The MRI segment
is sub-segmented into low to mid-field MRI systems, high and very high field
MRI systems, and ultra-high field MRI systems. Other sub-segmentations of key
segments are provided in the report.
By application, the market is segmented into product type,
and then further segmented by applications for each product type. Key segments
include MRI systems, CT scanners, nuclear imaging systems, X-ray imaging
systems, and ultrasound imaging systems. ultrasound systems are further
segmented into obstetrics, general imaging, cardiology, urology, vascular, and
others. Further sub-segmentation can be found in the report.
By end-user, the market is segmented into hospitals &
clinics, research & academic institutes, diagnostic imaging centers, and
others.
Key Players
Profiled market players include Samsung Medison, Toshiba
Corporation, Narang Medical Limited, Fonar Corporation, Hologic Inc., Shimadzu
Corporation, Fujifilm Holdings Corporation, Siemens AG, General Electric
Company, Hitachi Ltd., Carestream Health, Esaote S.P.A, and Koninklijke Philips
N.V.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Market Highlights
According to MRFR analysis, Cell
Counting Market trends is expected to register a CAGR of 5.8% during
the forecast period of 2019 to 2025 and was valued at USD 8.47 Billion
in 2018.
Cell counting is important for research and serves as one of
the major steps in the majority of experiments. It is effectively utilized for
maintaining cell cultures. Moreover, another important application of cell
counting can be seen in the diagnosis of chronic diseases like cancer. For
instance, an increase in the number of white blood cells (WBC) may indicate the
possibility of cancerous growth in the body. Thus, cell counting is important
for microbiology, hematology and other medical specialties.
The growth of the global cell counting market is determined
by numerous factors such as increasing R&D expenditure, rising prevalence
of cancer, and product launches. However, the high cost of devices and product
recalls are projected to restrain the growth of the market during the forecast
period.
The Global Cell Counting Market is currently dominated by
several market players. The key players are involved in product launches,
expansion, and strategic collaborations to strengthen their market positions.
Recently in April 2019, the Nexcelom Bioscience LLC launched Cellaca MX
automated cell counter.
Regional Analysis
The Cell
Counting Market Report has been divided, by region, into the Americas,
Europe, Asia-Pacific, and the Middle East & Africa.
The Americas is anticipated to hold the largest market share
owing to the increase in the incidence of cancer and the presence of well-established
pharmaceutical and biotechnology industry. The cell counting market in the
Americas has further been branched into North America and Latin America, with
the North American market divided into the US and Canada.
The European cell counting market has been categorized as
Western Europe and Eastern Europe. The Western European market has further been
classified as Germany, France, the UK, Italy, Spain, and the rest of Western
Europe. The cell counting market in Asia-Pacific has been segmented into Japan,
China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the
presence of a large patient pool and expansion of healthcare facilities, the
market in Asia-Pacific is expected to be the fastest-growing. The cell counting
market in the Middle East & Africa has been divided into the Middle East
and Africa.
Segmentation
The Global Cell Counting Market has been segmented based on
product, application, and end-user.
The market, based on type, has been divided into consumables
and instruments. The consumable segment is likely to hold maximum
market share in the global cell counting market. This due to the repeated
purchase of the consumable compared with instrument products.
The global cell counting market based
on application has been segregated into research application,
clinical & diagnostic application, and others. The research application
segment is anticipated to hold the largest share in the market due to the
rising funding for stem cell research.
The end-user segments of the market are pharmaceutical
and biotechnology companies, hospitals, research institutes, and others. The
pharmaceutical and biotechnology companies’ segment is expected to hold the
largest share of the market, as these are used cell counting products in
research and development of new drugs and therapies.
Key Players
Some of the Key Players in the Global Cell Counting
Market are Thermo Fisher Scientific (US), Merck KGaA (Germany),
Danaher Corporation (US), Bio-Rad Laboratories, Inc. (US), Logos Biosystems,
Inc. (South Korea), Olympus Corporation (Japan), Agilent Technologies, Inc.
(US), PerkinElmer, Inc. (US), Sysmex Corporation (Japan), Abbott Laboratories
(US), and others.
The pain
patch market size is expected to reach USD 21324 Million by 2030 at
4.80% CAGR during the forecast period 2022-2030. Pain-relief patches also known
as pain patches can be easily purchased from pharmacies. They are available in
different types, however, most of the pain patches are used for managing both
short-term and long-term pain. This clearly means that a pain patch can be
prescribed for both acute and chronic pain conditions. This flexibility and
effectiveness helps the companies in the global market for pain patch grow as
the demand for these products remains strong throughout the year, and its easy
availability has given more boost to the market.
A pain patch market when placed on the skin
helps the skin absorb a certain amount of medication which helps prevent or
reduce pain. The medication easily gets absorbed into the bloodstream, however
the type of medication and patch prescribed by physicians may vary depending on
the actual need of the patients and levels of the pain. Prescription based pain
patches may include diclofenac epolamine, an anti-inflammatory nonsteroidal
drug, a local anesthetic known as lidocaine, and opioid pain medication.
For minor injuries, physicians recommend a
pain patch with diclofenac epolamine. This formula helps in reducing and
controlling minor pain caused due to muscle strains and sprains. This element
falls under the same group as ibuprofen and aspirin. Patients are asked to be
careful and not use such patches anywhere on a broken skin. A study published
by expert analysts has found that such pain patches can provide pain relief for
soft-tissue injuries with few adverse effects.
Pain Patch Market Key Players
Pain Patch Market Segmentation
For the scope of research, analysts have
segmented the pain
patch market Insights based on type, mode of administration, end users, and
therapeutic use.
Pain Patch Market Regional Overview
Industry experts have analyzed the global
pain patches market at different levels. The report brings information from
across the world and provides key insights into regional pain patch markets
from the Americas, which is the largest market in the world for pain patches.
The growth here is due to an increasing number of patients with chronic
diseases and spinal injury. The report also covers the European market where
demand for pain patches is on the rise. Other regional pain patch markets covered
in the report are Asia-Pacific and the Middle East and Africa. For each of
these regions, analysts have also presented country-level trends, predictions,
and market status details along with profiling of key players present in the
global pain patch market.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
According to the latest research report the
transarterial
chemoembolization (TACE) market size is projected to reach USD 15.61
Billion by 2030 at 4.90% CAGR during the forecast period 2022-2030.
Hepatocellular carcinoma (HCC) is a primary
malignancy of the liver and occurs mainly due to chronic liver disease and
cirrhosis. It is the third leading cause of cancer deaths worldwide, with over
500,000 people affected. Transarterial chemoembolization market is the
current standard of therapy for patients with intermediate-stage hepatocellular
carcinoma (HCC). Conventional TACE is considered as a standard treatment for
HCC.
Key Players
Segmentation
By Procedure Type
By Product Type
By End-User
By Region
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.